Transvenous Phrenic Nerve Stimulation for Treatment of Central Sleep Apnea: Five-Year Safety and Efficacy Outcomes

BACKGROUND: The remedē System Pivotal Trial was a prospective, multi-center, randomized trial demonstrating transvenous phrenic nerve stimulation (TPNS) therapy is safe and effectively treats central sleep apnea (CSA) and improves sleep architecture and daytime sleepiness. Subsequently, the remedē S...

Descripción completa

Detalles Bibliográficos
Autores principales: Costanzo, Maria Rosa, Javaheri, Shahrokh, Ponikowski, Piotr, Oldenburg, Olaf, Augostini, Ralph, Goldberg, Lee R, Stellbrink, Christoph, Fox, Henrik, Schwartz, Alan R, Gupta, Sanjaya, McKane, Scott, Meyer, Timothy E, Abraham, William T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092633/
https://www.ncbi.nlm.nih.gov/pubmed/33953626
http://dx.doi.org/10.2147/NSS.S300713

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092633/
https://www.ncbi.nlm.nih.gov/pubmed/33953626
http://dx.doi.org/10.2147/NSS.S300713

Ejemplares similares